Stockreport

MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer

MiNK Therapeutics, Inc.  (INKT) 
PDF Financing of $5.8 Million at a 25% premium will help advance the clinical development of MiNK-215, an armored-FAP-CAR-iNKTGKCC, LLC joins as a new investor with Katie Ch [Read more]